Published in World J Gastroenterol on March 14, 2016
International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol (1999) 9.11
Diagnosis and management of autoimmune hepatitis. Hepatology (2010) 5.27
Epitope spreading in immune-mediated diseases: implications for immunotherapy. Nat Rev Immunol (2002) 3.63
Meeting report: International Autoimmune Hepatitis Group. Hepatology (1993) 3.27
Th2 and regulatory immune reactions are increased in immunoglobin G4-related sclerosing pancreatitis and cholangitis. Hepatology (2007) 2.96
Long-term management of the successful adult liver transplant: 2012 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation. Liver Transpl (2013) 2.48
Diagnosis, pathogenesis, and treatment of autoimmune hepatitis after liver transplantation. Dig Dis Sci (2012) 2.18
Donor-specific HLA Antibodies Are Associated With Late Allograft Dysfunction After Pediatric Liver Transplantation. Transplantation (2015) 2.13
Complement component 4d immunostaining in liver allografts of patients with de novo immune hepatitis. Liver Transpl (2011) 2.10
Effects of cyclosporine on transplant tolerance: the role of IL-2. Am J Transplant (2007) 1.78
Posttransplant plasma cell hepatitis (de novo autoimmune hepatitis) is a variant of rejection and may lead to a negative outcome in patients with hepatitis C virus. Liver Transpl (2008) 1.68
Mycophenolate mofetil use is associated with decreased risk of late acute rejection in adult liver transplant recipients. Am J Transplant (2006) 1.66
Liver autoimmune serology: a consensus statement from the committee for autoimmune serology of the International Autoimmune Hepatitis Group. J Hepatol (2004) 1.57
"Plasma cell hepatitis" in liver allografts: identification and characterization of an IgG4-rich cohort. Am J Transplant (2013) 1.52
Immunohistochemical phenotyping of the inflammatory infiltrate in de novo autoimmune hepatitis after liver transplantation in children. Pediatr Transplant (2012) 1.38
Epitope spreading. Curr Opin Immunol (1996) 1.34
De-novo autoimmune hepatitis after liver transplantation. Lancet (1998) 1.30
Liver biopsy interpretation for causes of late liver allograft dysfunction. Hepatology (2006) 1.24
Frequent plasma cell hepatitis during telaprevir-based triple therapy for hepatitis C after liver transplantation. J Hepatol (2013) 1.12
What is the long-term outcome of the liver allograft? J Hepatol (2011) 1.09
Structural integrity and identification of causes of liver allograft dysfunction occurring more than 5 years after transplantation. Am J Surg Pathol (1995) 1.08
Progressive histological damage in liver allografts following pediatric liver transplantation. Hepatology (2006) 1.07
Development of autoimmune hepatitis following liver transplantation for primary biliary cirrhosis. Hepatology (1999) 1.05
Effects of immunosuppression and organ transplantation on the natural history and immunopathogenesis of hepatitis C virus infection. Transpl Infect Dis (2000) 1.04
Recurrence of autoimmune liver disease after liver transplantation: a systematic review. Liver Transpl (2006) 1.03
Risk for immune-mediated graft dysfunction in liver transplant recipients with recurrent HCV infection treated with pegylated interferon. Gastroenterology (2012) 1.01
Virus infection, antiviral immunity, and autoimmunity. Immunol Rev (2013) 1.00
Autoimmune hepatitis after liver transplantation. Clin Gastroenterol Hepatol (2011) 0.98
Response to steroids in de novo autoimmune hepatitis after liver transplantation. Hepatology (2002) 0.94
Immune-mediated complications of the graft in interferon-treated hepatitis C positive liver transplant recipients. J Hepatol (2010) 0.93
Patterns of recurrent hepatitis C after liver transplantation in a recent cohort of patients. Hum Pathol (2006) 0.92
De novo autoimmune hepatitis after liver transplantation. Semin Liver Dis (2011) 0.91
Induction of autoimmune hepatitis by pegylated interferon in a liver transplant patient with recurrent hepatitis C virus. Transplantation (2006) 0.91
Rejection and steroid dependence: unique risk factors in the development of pediatric posttransplant de novo autoimmune hepatitis. Am J Transplant (2007) 0.91
Pegylated interferon-induced immune-mediated hepatitis post-liver transplantation. Liver Transpl (2006) 0.90
Plasma cell hepatitis in hepatitis C virus patients post-liver transplantation: case-control study showing poor outcome and predictive features in the liver explant. Liver Transpl (2009) 0.90
Autoimmune liver diseases and recurrence after orthotopic liver transplantation: what have we learned so far? Transpl Int (2008) 0.90
Rapamycin successfully treats post-transplant autoimmune hepatitis. Am J Transplant (2005) 0.88
De novo autoimmune hepatitis subsequent to switching from type 2b to type 2a alpha-pegylated interferon treatment for recurrent hepatitis C after liver transplantation: report of a case. Surg Today (2011) 0.87
Graft dysfunction mimicking autoimmune hepatitis following liver transplantation in adults. Hepatology (2001) 0.87
Autoimmune liver disease, autoimmunity and liver transplantation. J Hepatol (2013) 0.87
De novo hepatitis with autoimmune antibodies and atypical histology: a rare cause of late graft dysfunction after pediatric liver transplantation. Transplantation (2001) 0.86
Antibodies against glutathione S-transferase T1 (GSTT1) in patients with de novo immune hepatitis following liver transplantation. Clin Exp Immunol (2001) 0.85
Immune-mediated liver dysfunction after antiviral treatment in liver transplanted patients with hepatitis C: allo or autoimmune de novo hepatitis? Dig Liver Dis (2009) 0.85
Autoimmune hepatitis as a late complication of liver transplantation. J Pediatr Gastroenterol Nutr (2001) 0.84
De novo autoimmune hepatitis in Korean children after liver transplantation: a single institution's experience. Transplant Proc (2011) 0.84
Plasma cell hepatitis (de-novo autoimmune hepatitis) developing post liver transplantation. Curr Opin Organ Transplant (2012) 0.84
Interface hepatitis is associated with a high incidence of late graft fibrosis in a group of tightly monitored pediatric orthotopic liver transplantation patients. Liver Transpl (2008) 0.84
Antibodies against cytokeratin 8/18 in a patient with de novo autoimmune hepatitis after living-donor liver transplantation. Liver Transpl (2005) 0.83
De novo autoimmune hepatitis after liver transplantation. J Hepatol (2004) 0.83
Risk factors for developing de novo autoimmune hepatitis associated with anti-glutathione S-transferase T1 antibodies after liver transplantation. Liver Transpl (2009) 0.83
Glutathione S-transferase T1 mismatch constitutes a risk factor for de novo immune hepatitis after liver transplantation. Liver Transpl (2004) 0.83
Posttransplant immune hepatitis in pediatric liver transplant recipients: incidence and maintenance therapy with azathioprine. Transplantation (2001) 0.83
Late graft dysfunction and autoantibodies after liver transplantation in children: preliminary results of an Italian experience. Liver Transpl (2006) 0.82
Hepatitis C virus infection in the immunocompromised host: a complex scenario with variable clinical impact. J Transl Med (2012) 0.82
Successful treatment of de novo autoimmune hepatitis and cirrhosis after pediatric liver transplantation. Pediatr Transplant (2006) 0.82
G-CSF in Peg-IFN induced neutropenia in liver transplanted patients with HCV recurrence. World J Gastroenterol (2009) 0.82
De novo autoimmune hepatitis with centrilobular necrosis following liver transplantation for primary biliary cirrhosis: a case report. Transplant Proc (2010) 0.82
Genome-wide association study of hepatitis C virus- and cryoglobulin-related vasculitis. Genes Immun (2014) 0.81
Outcome and risk factors of de novo autoimmune hepatitis in living-donor liver transplantation. Transplantation (2004) 0.80
De novo autoimmune hepatitis following liver transplantation for primary biliary cirrhosis. Transplant Proc (2006) 0.80
Autoimmunity after liver transplantation: a frequent event but a rare clinical problem. Clin Transplant (2015) 0.79
De novo autoimmune hepatitis after living donor liver transplantation is unlikely to be related to immunoglobulin subtype 4-related immune disease. J Gastroenterol Hepatol (2008) 0.79
Autoantibody appearance in cytomegalovirus-infected liver transplant recipients: correlation with antigenemia. J Med Virol (2002) 0.79
Histologic findings predictive of a diagnosis of de novo autoimmune hepatitis after liver transplantation in adults. Transplantation (2013) 0.79
A cause of late graft dysfunction after pediatric liver transplantation: de novo autoimmune hepatitis. Transplant Proc (2002) 0.78
Recurrent and de novo autoimmune liver diseases. Clin Liver Dis (2011) 0.78
Concurrent de novo autoimmune hepatitis and recurrence of primary biliary cirrhosis post-liver transplantation. Liver Transpl (2001) 0.78
Post-liver transplantation de novo hepatitis with overlap features. Pathol Int (2005) 0.78
De novo autoimmune hepatitis following living-donor liver transplantation for primary biliary cirrhosis. Clin Transplant (2008) 0.78
Tolerance profiles and immunosuppression. Liver Transpl (2013) 0.78
Recurrent hepatitis C virus after transplant and the importance of plasma cells on biopsy. World J Gastroenterol (2013) 0.77
Immunoglobulin G4-associated de novo autoimmune hepatitis after liver transplantation for chronic hepatitis B- and C-related cirrhosis and hepatocellular carcinoma: a case report with literature review. Transplant Proc (2013) 0.77
Effectiveness and safety of everolimus in the treatment of autoimmune hepatitis related to anti-hepatitis C virus therapy after liver transplant: three case reports. Transplant Proc (2011) 0.77
Choice of calcineurin inhibitor may influence the development of de novo immune hepatitis associated with anti-GSTT1 antibodies after liver transplantation. Clin Transplant (2011) 0.77
De novo autoimmune hepatitis affecting allograft but not the native liver in auxiliary partial orthotopic liver transplantation. Transplantation (2003) 0.77
Histopathological evaluation of recurrent hepatitis C after liver transplantation: a review. World J Gastroenterol (2014) 0.77
De novo ulcerative colitis and autoimmune hepatitis after living related liver transplantation from cytomegalovirus-positive donor to cytomegalovirus-negative recipient: a case report. Transplant Proc (2012) 0.77
A cause of late graft dysfunction after liver transplantation in children: de-novo autoimmune hepatitis. Transplant Proc (2001) 0.77
Glutathione S-transferase T1 genetic mismatch is a risk factor for de novo immune hepatitis in liver transplantation. Transplant Proc (2005) 0.77
De novo autoimmune hepatitis after living donor liver transplantation in a 25-day-old newborn baby: a case report. Transplant Proc (2009) 0.76
Monitoring "de novo" autoimmune hepatitis (LKM positive) by serum type-IV collagen after liver transplant: a paediatric case. Clin Chim Acta (2001) 0.76
Antibodies against glutathione S-transferase T1 in patients with immune hepatitis after liver transplantation. Transplant Proc (2003) 0.75